IGKV2D-29

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, IGKV2D-29 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated IGKV2D-29 data layer compared with 6 for mutation status and 7 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher IGKV2D-29 RNA is associated with better overall survival. In most high-consensus cancer types, elevated IGKV2D-29 expression acts as an unfavorable survival marker, although some lineages such as HNSC and BRCA show a favorable association.

HNSC, BRCA, and COAD are the cancer types where IGKV2D-29 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
HNSCOSMedianIII,IV0.4620.294<.001138view →
BRCADFSQuartileAll0.6570.461<.00160view →
COADOSMedianAll0.8710.748.00246view →
SKCMOSMedianIII,IV0.9340.728.00138view →
UCECDFSMedianIII,IV0.7070.394.00138view →
LIHCOSTertileAll0.8170.705.00524view →
STADOSMedianIV0.6420.203.00624view →
SARCDFSQuartileAll0.6620.465.00324view →
UVMDFSQuartileAll0.3640.661.00718view →
ACCDFSTertileIII,IV0.0950.431.01515view →
READDFSQuartileIV0.8890.452.01014view →
CESCOSMedianII,III,IV0.8960.745.01814view →
Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

IGKV2D-29–HNSC (OS)

Kaplan–Meier survival curve for IGKV2D-29 RNA-high vs -low samples in HNSC.

Open the HNSC breakdown →

Exploration